Clinical Trial

Angiogenesis in Periodontal Disease

Completed
View on ClinicalTrials.gov →
Summary
Gum disease (gingivitis and periodontitis) is a common inflammatory condition affecting the tissues that support the teeth. Smoking is known to make gum disease worse and to affect blood vessel health in the gums. This study looks at two proteins, KLF2 and FBXW7, which are involved in blood vessel formation, to understand their role in gum disease and whether smoking changes their levels. Researchers measured these proteins, along with two other markers of inflammation and blood vessel activity (VEGF and NF-κB), in fluid collected from around the teeth and in saliva from healthy adults who were either smokers or non-smokers, with healthy gums, gingivitis, or periodontitis. The goal is to better understand how smoking and gum disease affect blood vessel-related proteins in the mouth.
Trial Details
NCT Number NCT07765251
Lead Sponsor Inonu University
Conditions Gingivitis
Enrollment 114 participants
Start Date 2024-03-01
Primary Completion 2024-09-30 (estimated)
Study Completion 2024-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-14